DEVAZEPIDE
![]() |
- ₹20719.05 - ₹83688.08
- Product name: DEVAZEPIDE
- CAS: 103420-77-5
- MF: C25H20N4O2
- MW: 408.45
- EINECS:
- MDL Number:MFCD00864500
- Synonyms:N-[(3S)-2,3-DIHYDRO-1-METHYL-2-OXO-5-PHENYL-1H-1,4-BENZODIAZEPIN-3-YL]-1H-INDOLE-2-CARBOXAMIDE;DEVAZEPIDE;EVAZEPIDE, PANOS;(3S)-1-Methyl-3-[(1H-indol-2-yl)carbonylamino]-5-phenyl-1H-1,4-benzodiazepin-2(3H)-one;L-364718;MK-329;(S)-N-(2,3-Dihydro-1-methyl-2-oxo-5-phenyl-1H-1,4-benzodiazepin-3-yl)indole-2-carboxamide;1H-Indole-2-carboxamide, N-[(3S)-2,3-dihydro-1-methyl-2-oxo-5-phenyl-1H-1,4-benzodiazepin-3-yl]-
2 prices
Selected condition:
Brand
- Sigma-Aldrich(India)
Package
- 5MG
- 25MG
- ManufacturerSigma-Aldrich(India)
- Product numberD3821
- Product descriptionDevazepide ≥98% (HPLC), powder
- Packaging25MG
- Price₹83688.08
- Updated2022-06-14
- Buy
- ManufacturerSigma-Aldrich(India)
- Product numberD3821
- Product descriptionDevazepide ≥98% (HPLC), powder
- Packaging5MG
- Price₹20719.05
- Updated2022-06-14
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
Sigma-Aldrich(India) | D3821 | Devazepide ≥98% (HPLC), powder | 25MG | ₹83688.08 | 2022-06-14 | Buy |
Sigma-Aldrich(India) | D3821 | Devazepide ≥98% (HPLC), powder | 5MG | ₹20719.05 | 2022-06-14 | Buy |
Properties
Boiling point :758.6±60.0 °C(Predicted)
Density :1.31±0.1 g/cm3(Predicted)
storage temp. :2-8°C
solubility :DMSO: >5mg/mL
pka :13.25±0.40(Predicted)
form :powder
color :white to off-white
Density :1.31±0.1 g/cm3(Predicted)
storage temp. :2-8°C
solubility :DMSO: >5mg/mL
pka :13.25±0.40(Predicted)
form :powder
color :white to off-white
Safety Information
Symbol(GHS): |
![]() |
||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Signal word: | Danger | ||||||||||||||
Hazard statements: |
|
||||||||||||||
Precautionary statements: |
|
Description
Devazepide is a non-peptide CCK (cholecystokinin) receptor antagonist. CCK is a neuroendocrine peptide described to play an important role in cell growth, cell proliferation, and other biological functions. Studies indicate that Devazepide induces apoptosis in Ewing tumor growth studies, and does not reverse the blocking affect of IL-1β in rat studies. In addition, Devazepide has been reported to inhibit the growth of HT29-S-B6 cells and affect the cells morphology.More related product prices
Related product price
- DEVAZEPIDE
₹20719.05-83688.08